Patient Empowerment and Self-Management Neurotechnology to Watch in 2018

Tools to help users monitor and detect tinnitus, control post-stroke symptoms, improve seizure monitoring, and more.

Related Videos
Related Content

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023

Neuro News Roundup: TBI Awareness Month

March 31st 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

Raising Awareness on Traumatic Brain Injury and Significance of Abbott’s Approved Alinity i Lab-Based Blood Test

March 31st 2023

Episode 81: Widening the Therapeutic Window in Parkinson Disease

January 27th 2023

Blarcamesine Deemed Safe, Effective in Phase 2 Extension Study of Parkinson Disease Dementia

March 30th 2023

New Analysis of Phase 3 Clarity AD Study Highlights Health and Economic Benefits From Lecanemab

March 27th 2023
© 2023 MJH Life Sciences

All rights reserved.